ACI: Q4 saw lower profits from salt but strong bromine growth, with recovery expected as costs ease

About this update from Archean Chemical Industries Ltd.

Q4 FY 2026 saw lower revenue and EBITDA due to logistics and pricing pressures in industrial salt, while bromine and derivatives showed strong volume and price growth. Strategic initiatives include brine field expansion and a new semiconductor project, with margin recovery expected as costs normalize.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Archean Chemical Industries Ltd.